Ann-Margaret Navarra, PHD, CPNP, FAAN, associate dean for nursing innovation at Stony Brook University School of Nursing, recently co-published research examining antiretroviral therapy (ART) adherence in young people living with HIV.
The study, which Dr. Navarra published alongside colleagues from institutions around the country and at Stony Brook’s Renaissance School of Medicine and College of Engineering and Applied Sciences, sought to “characterize ART adherence phenotypes and psychosocial symptom clusters, as related to ART adherence and HIV viral load suppression.”
Sixty adolescents and young adults (AYAs) with HIV enrolled in an ART adherence support clinical trial and self-reported ART adherence at three points: baseline, 12 weeks, and 24 weeks. The data were used to define four phenotypes of ART adherence: consistently high adherence (YY), early-only adherence (YN), late-only adherence (NY), and consistently low adherence (NN).
According to the study, the findings “contribute to improved understanding of the multi-level psychosocial influences of ART adherence and viral load suppression.”
Click here to read the study in full.
A Trailblazer in HIV/AIDS Research
Earlier this year, Dr. Navarra was selected as one of the first ten innovators for the Nursing Science Incubator for Social Determinants of Health (SDOH) Solutions (N-SISS) Fellowship at the Institute for Policy Solutions (IPS) at Johns Hopkins School of Nursing.
This highly competitive fellowship recognizes her outstanding qualifications, innovative research, and commitment to addressing healthcare inequities in the U.S. through the lens of SDOH.
A leader in nursing science, Dr. Navarra has a research focus on HIV/AIDS, pediatrics, chronic disease, and underserved populations. In the 1990s, she was a trailblazer in advanced practice pediatric nursing, spearheading care initiatives for youth living with HIV/AIDS. Her early work in this field became the foundation for her significant contributions to HIV behavioral sciences and health equity.
